- Home
- FET vs TLSA Comparison
FET vs TLSA Comparison
Compare FET & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FET
- TLSA
- Stock Information
- Founded
- FET 2005
- TLSA 2013
- Country
- FET United States
- TLSA United Kingdom
- Employees
- FET N/A
- TLSA N/A
- Industry
- FET Metal Fabrications
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- FET Industrials
- TLSA Health Care
- Exchange
- FET Nasdaq
- TLSA Nasdaq
- Market Cap
- FET 187.2M
- TLSA 175.3M
- IPO Year
- FET 2012
- TLSA 2000
- Fundamental
- Price
- FET $19.98
- TLSA $1.59
- Analyst Decision
- FET
- TLSA
- Analyst Count
- FET 0
- TLSA 0
- Target Price
- FET N/A
- TLSA N/A
- AVG Volume (30 Days)
- FET 91.6K
- TLSA 261.4K
- Earning Date
- FET 07-31-2025
- TLSA 07-11-2025
- Dividend Yield
- FET N/A
- TLSA N/A
- EPS Growth
- FET N/A
- TLSA N/A
- EPS
- FET N/A
- TLSA N/A
- Revenue
- FET $807,312,000.00
- TLSA N/A
- Revenue This Year
- FET N/A
- TLSA N/A
- Revenue Next Year
- FET $1.73
- TLSA N/A
- P/E Ratio
- FET N/A
- TLSA N/A
- Revenue Growth
- FET 7.31
- TLSA N/A
- 52 Week Low
- FET $12.78
- TLSA $0.63
- 52 Week High
- FET $21.57
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- FET 64.28
- TLSA 53.42
- Support Level
- FET $18.75
- TLSA $1.54
- Resistance Level
- FET $19.85
- TLSA $1.81
- Average True Range (ATR)
- FET 0.86
- TLSA 0.12
- MACD
- FET 0.08
- TLSA 0.01
- Stochastic Oscillator
- FET 75.05
- TLSA 50.00
About FET Forum Energy Technologies Inc.
Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.